Acknowledgement
The present research was supported by a grant from the Korea Institute of Oriental Medicine (KIOM; Evaluation of Herb-Drug Interactions, K16252).
References
- Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420-429. https://doi.org/10.1053/j.gastro.2017.04.022
- Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19 Suppl 1:1-5. https://doi.org/10.1111/hel.12165
- O'Connor A, Lamarque D, Gisbert JP, O'Morain C. Treatment of Helicobacter pylori infection 2017. Helicobacter. 2017;22 Suppl 1.
- Ayala G, Escobedo-Hinojosa WI, de la Cruz-Herrera CF, Romero I. Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol. 2014;20(6):1450-1469. https://doi.org/10.3748/wjg.v20.i6.1450
- Haesebrouck F, Pasmans F, Flahou B, Chiers K, Baele M, Meyns T, Decostere A, Ducatelle R.Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Clin Microbiol Rev. 2009;22(2):202-223. https://doi.org/10.1128/CMR.00041-08
- Sykes J, Greene C. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis: Saunders; 2012, p 374-380.
- Neiger R, Simpson KW. Helicobacter infection in dogs and cats: facts and fiction. J Vet Intern Med. 2000;14(2):125-133. https://doi.org/10.1892/0891-6640(2000)014<0125:IIDACF>2.3.CO;2
- Sharma SA, Tummuru MK, Miller GG, Blaser MJ. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun. 1995;63(5):1681-1687. https://doi.org/10.1128/iai.63.5.1681-1687.1995
- Handa O, Naito Y, Yoshikawa T. Helicobacter pylori: a ROS-inducing bacterial species in the stomach. Inflamm Res. 2010;59(12):997-1003. https://doi.org/10.1007/s00011-010-0245-x
- Tiwari SK, Manoj G, Sharma V, Sivaram G, Saikant R, Bardia A, Sharma VK, Abid Z, Khan AA, Habeeb MA, Habibullah CM, Kumar BS, Nandan A. Relevance of Helicobacter pylori genotypes in gastric pathology and its association with plasma malondialdehyde and nitric oxide levels. Inflammopharmacology. 2010;18(2):59-64. https://doi.org/10.1007/s10787-010-0031-y
- Slomiany BL, Slomiany A. Induction in gastric mucosal prostaglandin and nitric oxide by Helicobacter pylori is dependent on MAPK/ERK-mediated activation of IKK-β and cPLA2: modulatory effect of ghrelin. Inflammopharmacology. 2013;21(3):241-251. https://doi.org/10.1007/s10787-013-0169-5
- Kim OS, Kim Y, Yoo SR, Lee MY, Shin HK, Jeong SJ. Cheonwangbosimdan, a traditional herbal formula, inhibits inflammatory responses through inactivation of NF-κB and induction of heme oxygenase-1 in raw264. 7 murine macrophages. Int J Clin Exp Med. 2016;9(2):1692-1699.
- Kim NJ, Kong YY, Chang SW. Studies on the efficacy of combined preparation of crude drugs (XXXVII). The effects of chunwangboshimdan on the central nervous system and cardio-vascular system. Korean J Pharmacogn. 1988;19(3):208-215.
- Kim B, Jo C, Choi HY, Lee K. Vasorelaxant and hypotensive effects of Cheonwangbosimdan in SD and SHR rats. Evid Based Complement Alternat Med. 2018;2018:6128604.
- Thompson LJ, Danon SJ, Wilson JE, O'Rourke JL, Salama NR, Falkow S, Mitchell H, Lee A. Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun. 2004;72(8):4668-4679. https://doi.org/10.1128/IAI.72.8.4668-4679.2004
- Shinilbooks Committee. The Korean Herbal Pharmacopoeia. 5th ed. Seoul: Shinilbooks; 2016, p 458.
- Seo CS, Kim OS, Shin HK. Quantitative determination and antioxidant effects of Cheonwangbosimdan. Korean J Pharmacogn. 2014;45(4):300-314.
- Seo CS, Shin HK. Development and validation of a high-performance liquid chromatographic method for the simultaneous quantification of marker constituents in Cheonwangbosimdan. Nat Prod Commun. 2014;9(12):1751-1754.
- Park HS, Wijerathne CU, Jeong HY, Seo CS, Ha H, Kwun HJ. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury. J Ethnopharmacol. 2018;216:239-250. https://doi.org/10.1016/j.jep.2018.01.025
- Crabtree JE, Lindley IJ. Mucosal interleukin-8 and Helicobacter pylori-associated gastroduodenal disease. Eur J Gastroenterol Hepatol. 1994;6 Suppl 1:S33-S38.
- Huang HL, Ko CH, Yan YY, Wang CK. Antiadhesion and anti-inflammation effects of noni (Morinda citrifolia) fruit extracts on AGS cells during Helicobacter pylori infection. J Agric Food Chem. 2014;62(11):2374-2383. https://doi.org/10.1021/jf405199w
- Drake IM, Mapstone NP, Schorah CJ, White KL, Chalmers DM, Dixon MF, Axon AT. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H pylori eradication. Gut. 1998;42(6):768-771. https://doi.org/10.1136/gut.42.6.768
- Saeidi E, Sheikhshahrokh A. vacA genotype status of Helicobacter pylori isolated from foods with animal origin. Biomed Res Int. 2016;2016:8701067. https://doi.org/10.1155/2016/8701067
- Momtaz H, Dabiri H, Souod N, Gholami M. Study of Helicobacter pylori genotype status in cows, sheep, goats and human beings. BMC Gastroenterol. 2014;14(1):61. https://doi.org/10.1186/1471-230X-14-61
- Vega AE, Wendel GH, Maria AO, Pelzer L. Antimicrobial activity of Artemisia douglasiana and dehydroleucodine against Helicobacter pylori. J Ethnopharmacol. 2009;124(3):653-655. https://doi.org/10.1016/j.jep.2009.04.051
- Bonifacio BV, dos Santos Ramos MA, da Silva PB, Bauab TM. Antimicrobial activity of natural products against Helicobacter pylori: a review. Ann Clin Microbiol Antimicrob. 2014;13(1):54. https://doi.org/10.1186/PREACCEPT-1712290149140143
- Li MM, Wu LY, Zhao T, Xiong L, Huang X, Liu ZH, Fan XL, Xiao CR, Gao Y, Ma YB, Chen JJ, Zhu LL, Fan M. The protective role of 5-HMF against hypoxic injury. Cell Stress Chaperones. 2011;16(3):267-273. https://doi.org/10.1007/s12192-010-0238-2
- Kong F, Lee BH, Wei K. 5-hydroxymethylfurfural mitigates lipopolysaccharide-stimulated inflammation via suppression of MAPK, NF-κB and mTOR activation in RAW 264.7 cells. Molecules. 2019;24(2):275. https://doi.org/10.3390/molecules24020275
- Li C, Huang P, Wong K, Xu Y, Tan L, Chen H, Lu Q, Luo C, Tam C, Zhu L, Su Z, Xie J. Coptisine-induced inhibition of Helicobacter pylori: elucidation of specific mechanisms by probing urease active site and its maturation process. J Enzyme Inhib Med Chem. 2018;33(1):1362-1375. https://doi.org/10.1080/14756366.2018.1501044
- Lee IA, Hyun YJ, Kim DH. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation. Eur J Pharmacol. 2010;648(1-3):162-170. https://doi.org/10.1016/j.ejphar.2010.08.046
- The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. version 9.0 [Internet]. Vaxjo: The European Committee on Antimicrobial Susceptibility Testing; http://www.eucast.org/clinical_breakpoints. Updated 2019.
- Clinical and Laboratory Standards Institute (CLSI). Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. 3rd ed. Wayne: CLSI; 2016.
- Backert S, Clyne M. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2011;16 Suppl 1:19-25. https://doi.org/10.1111/j.1523-5378.2011.00876.x
- Lee KE, Khoi PN, Xia Y, Park JS, Joo YE, Kim KK, Choi SY, Jung YD. Helicobacter pylori and interleukin-8 in gastric cancer. World J Gastroenterol. 2013;19(45):8192-8202. https://doi.org/10.3748/wjg.v19.i45.8192
- Siddiqui RA, Akard LP, Garcia JG, Cui Y, English D. Chemotactic migration triggers IL-8 generation in neutrophilic leukocytes. J Immunol. 1999;162(2):1077-1083.
- Berg K, Chatterjee A, Yasmin T, Shara M, Bagchi D. Cytokine expression due to Helicobacter pylori in a tissue culture model. Mol Cell Biochem. 2007;300(1-2):171-175. https://doi.org/10.1007/s11010-006-9380-7
- Wang YK, Chiang WC, Kuo FC, Wu MC, Shih HY, Wang SSW, Liu CJ, Chen YH, Wu DC, Su WW, Huang YL. Levels of malondialdehyde in the gastric juice: its association with Helicobacter pylori infection and stomach diseases. Helicobacter. 2018;23(2):e12460. https://doi.org/10.1111/hel.12460
- Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology. 1999;116(6):1319-1329. https://doi.org/10.1016/S0016-5085(99)70496-8
- Cho SO, Lim JW, Kim KH, Kim H. Involvement of Ras and AP-1 in Helicobacter pylori-induced expression of COX-2 and iNOS in gastric epithelial AGS cells. Dig Dis Sci. 2010;55(4):988-996. https://doi.org/10.1007/s10620-009-0828-y
- Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001;15(9):1271-1290. https://doi.org/10.1046/j.1365-2036.2001.01052.x